Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study (Q33803763)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

lupus erythematosus

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

object named as

Anne Davidson

10

0 references

9

object named as

Betty Diamond

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Cynthia Aranow

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

object named as

Meggan Mackay

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

object named as

Inaki Sanz

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Annett M Jacobi

1

object named as

Annett M Jacobi

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Richard A Furie

6

object named as

Richard Furie

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Weiqing Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tao Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

William Freimuth

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

201-210

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Human B cell memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

The role of IL-21 in regulating B-cell function in health and disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Phenotypic and functional heterogeneity of human memory B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BAFF, APRIL and their receptors: structure, function and signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Similarities and differences between selective and nonselective BAFF blockade in murine SLE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BLyS and APRIL in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BCMA is essential for the survival of long-lived bone marrow plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Splenic T zone development is B cell dependent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

4 July 2018

Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

1 reference

https://api.crossref.org/works/10.1002%2FART.27189

21 January 2018

Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

30 October 2018

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

30 October 2018

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

30 October 2018

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857977

30 October 2018

Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.27189

21 January 2018

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF overexpression is associated with autoantibody production in autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95

1 reference

https://pubmed.ncbi.nlm.nih.gov/20039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.27189

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33803763&oldid=1744835328"